Welcome to LookChem.com Sign In|Join Free
  • or
D(+)-Carnitine, also known as the (S)-enantiomer of carnitine, is an essential cofactor of fatty acid metabolism that plays a crucial role in the transport of fatty acids through the inner mitochondrial membrane. It is primarily synthesized in the liver and kidney, with the highest concentrations found in heart and skeletal muscle. D(+)-Carnitine is a white to light yellow crystal powder and can be obtained from dietary sources such as red meat, dairy products, beans, and avocado.

541-14-0

Post Buying Request

541-14-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

541-14-0 Usage

Uses

Used in Pharmaceutical Industry:
D(+)-Carnitine is used as a therapeutic agent for various conditions related to fatty acid metabolism, including cardiovascular diseases, metabolic disorders, and muscle fatigue. Its role in the transport of fatty acids across the inner mitochondrial membrane aids in energy production and supports overall cellular function.
Used in Sports Nutrition:
D(+)-Carnitine is used as a supplement in the sports nutrition industry to enhance endurance, improve athletic performance, and reduce muscle fatigue. Its involvement in fatty acid metabolism helps in providing energy during intense physical activities.
Used in Weight Management:
D(+)-Carnitine is used as a weight management aid, as it may help in the breakdown of fats for energy production, thus supporting weight loss and maintaining a healthy body composition.
Used in Animal Nutrition:
D(+)-Carnitine is used as a feed additive in the animal nutrition industry to improve the health and performance of livestock, particularly in poultry and pigs. It helps in enhancing energy metabolism, growth, and overall productivity.
Used in Cosmetics:
D(+)-Carnitine is used in the cosmetics industry for its potential anti-aging and skin health benefits. It may help in improving skin elasticity, reducing the appearance of fine lines and wrinkles, and promoting a more youthful complexion.

Check Digit Verification of cas no

The CAS Registry Mumber 541-14-0 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,4 and 1 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 541-14:
(5*5)+(4*4)+(3*1)+(2*1)+(1*4)=50
50 % 10 = 0
So 541-14-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H15NO3/c1-8(2,3)5-6(9)4-7(10)11/h6,9H,4-5H2,1-3H3

541-14-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name (S)-carnitine

1.2 Other means of identification

Product number -
Other names bicarnesine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:541-14-0 SDS

541-14-0Relevant academic research and scientific papers

PROCESS FOR THE PRODUCTION OF CARNITINE BY CYCLOADDITION

-

Page/Page column 10, (2012/02/03)

The invention relates to a method for the production of L-carnitine, wherein a chiral β-lactone carnitine precursor is obtained by a [2+2] cycloaddition of ketene with an aldehyde X—CH2—CHO, wherein X is selected from Cl, Br, I and trimethylamine, in the presence of a chiral catalyst.

An efficient, highly enantioenriched route to L-carnitine and α-lipoic acid via hydrolytic kinetic resolution

Bose, D. Subhas,Fatima, Liyakat,Rajender, Salla

, p. 1863 - 1867 (2008/01/27)

A general and practical approach for the synthesis of C-4 chiral building blocks using Jacobsen's hydrolytic kinetic resolution technique to resolve terminal epoxides and diols in high enantiomeric excess and excellent yields is described. The utilization of these building blocks for the synthesis of biologically important natural products L-carnitine and α-lipoic acid is illustrated. Georg Thieme Verlag Stuttgart.

Retention and selectivity of teicoplanin stationary phases after copper complexation and isotopic exchange

Berthod,Valleix,Tizon,Leonce,Caussignac,Armstrong

, p. 5499 - 5508 (2007/10/03)

Teicoplanin is a macrocyclic glycopeptide that is highly effective as a chiral selector for LC enantiomeric separations. Two possible interaction paths were investigated and related to solute retention and selectivity: (1) interactions with the only teicoplanin amine group and (2) role of hydrogen bonding interactions. Mobile phases containing 0.5 and 5 mM copper ions were used to try to block the amine group. In the presence of copper ions, it was found that the teicoplanin stationary phase has a decreased ability to separate most underivatized racemic amino acids. However, it maintained its ability to separate enantiomers that were not α - amino acids. It is established that there is little copper - teicoplanin complex formation. The effect of Cu2+ on the enantioseparation of some α - amino acids appears to be due to the fact that these solutes are good bidentate ligands and form complexes with copper ions in the mobile phase. Isotopic exchange with deuterium oxide was performed using acetonitrile - heavy water mobile phases. It was found that the retention times of all amino acids were lower with deuterated mobile phases. The retention times of polar or apolar molecules without amine groups were higher with deuterated mobiles phases. In all cases, the enantio-selectivity factors were unaffected by the deuterium exchange. It is proposed that the electrostatic interactions are decreased in the deuterated mobile phases and the solute-accessible stationary-phase volume is somewhat swollen by deuterium oxide. The balance of these effects is a decrease in the amino acid retention times and an increase in the apolar solute retention time. The enantio-selectivity factors of all of the molecules remain unchanged because all of the interactions are changed equally. We propose a new global quality criterion (the E factor) for comparing and evaluating enantiomeric separations.

Asymmetric synthesis of (S)-(+)-carnitine and analogs

Jain, Rajendra P,Williams, Robert M

, p. 6505 - 6509 (2007/10/03)

A general asymmetric route to enantiomerically pure (S)-(+)-carnitine and analogs has been investigated that involves mono-addition of organometallic reagents to the lactone carbonyl group of (5R,6S)-4-(benzyloxycarbonyl)-5,6-diphenyl-2,3,5,6-tetrahydro-4H-1,4-oxazin- 2-one and Lewis acid promoted stereoselective allylation of the resulting hemiacetals. The diastereomerically pure allyl oxazines thus obtained were readily converted into enantiomerically pure (S)-(+)-carnitine and two substituted analogs.

Phosphinyloxy propanaminium inner salt derivatives

-

, (2008/06/13)

Compounds of the formula STR1 where X1 and X2 are independently O or S, and R1 is as defined in the description R2, R3, and R4 are each independently straight or branched chain (C1-4)alkyl, and pharmaceutically acceptable salts, physiological hydrolysable esters, and pro-drug forms thereof are useful as hypoglycemic agents.

Process for preparing phosphinyloxy propanaminium inner salt derivatives

-

, (2008/06/13)

A process for preparing compounds of the formula STR1 where X1 and X2 are independently O or S, and R1 is as defined herein, R2, R3, and R4 are each independently straight or branched chain (C1-4)alkyl, and pharmaceutically acceptable salts, physiological hydrolyzable esters, and pro-drug forms thereof, which are useful as hypoglycemic agents.

A new, short and efficient synthesis of both enantiomers of carnitine

Bellamy,Bondoux,Dodey

, p. 7323 - 7326 (2007/10/02)

A short, efficient and enantioselective synthesis of both (R) and (S) enantiomers of carnitine is reported starting with (R) or (S) malic acid and involving a chemoselective reduction step.

ON THE STERIC COURSE OF BAKER' S YEAST MEDIATED REDUCTION OF ALKYL 4-AZIDO-AND 4-BROMO-3-OXOBUTYRATE. SYNTHESIS OF (R)- AND (S)-CARNITIN

Fuganti, Claudio,Grasselli, Piero

, p. 101 - 104 (2007/10/02)

Baker's yeast reduction of ethyl 4-azido-and 4-bromo-3-oxobutyrate affords (3R) (8) and (3S) (2), respectively, in high optical purity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 541-14-0